Skip to content
sellWeak10b5-1 plan

Kevin James Craig sold $355k of ATAI

Chief Medical Officer at AtaiBeckley Inc.. 100,000 shares at an average of $3.55, traded Mar 20, 2026, filed Mar 24, 2026.

Warning score
15
Value
$355k
100,000 shares
Holdings after
8,437
-92% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet

Score components

  • Role
    Officer
    +15
  • Trade size
    $355k at market
    +15
  • Share of holdings sold
    Sold 92% of holdings
    +20
  • Cluster
    No other insider selling within 14 days
    0
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -, 3m -, 6m +1.8%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

ATAISep 11, 2026 · close 7.35
Since filing Jul 17, 2026: +1.8%SPY +19.7% · excess -17.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001140361-26-010932, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Mar 20, 2026MOption exercise
Common Stock10b5-1
+76,224$1.18$90k84,661Mar 24, 2026
Mar 20, 2026MOption exercise
Common Stock10b5-1
+23,776$1.50$36k108,437Mar 24, 2026
Mar 20, 2026SOpen-market sale
Common Stock10b5-1
-100,000$3.55$355k8,437Mar 24, 2026
Mar 20, 2026MOption exercise
Stock Optionderivative10b5-1
-76,224$0.00$038,136Mar 24, 2026
Mar 20, 2026MOption exercise
Stock Optionderivative10b5-1
-23,776$0.00$0734,139Mar 24, 2026

Related signals

Other insiders at AtaiBeckley Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
33Weak
ATAIsell 310b5-1
AtaiBeckley Inc.
Robert Hershberg
director
$496k
100,000 shares
-50%
33Weak
ATAIsell 310b5-1
AtaiBeckley Inc.
Gerd Kochendoerfer
Chief Operating Officer
$250k
50,000 shares
-100%
27Weak
ATAIsell 310b5-1
AtaiBeckley Inc.
Kevin James Craig
Chief Medical Officer
$192k
42,579 shares
-83%
12Weak
ATAIsell10b5-1
AtaiBeckley Inc.
Kevin James Craig
Chief Medical Officer
$213k
42,579 shares
-83%
26Weak
ATAIsell
AtaiBeckley Inc.
Cosmo Feilding-Mellen
director
$154k
39,594 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kevin James Craig sold $355k of ATAI | InsiderTell